Ysios Capital
Ysios Capital
Ysios Capital is a leading life sciences investor financing highly innovative companies worldwide.
- Use: Go2Market;
- Date closing: -
- Amount: -
- Industry focus: Health;
- Total budget: 216M €
- Entity type: Venture Capital
- Vertical focus: biotechnology, emerging pharmaceuticals, healthcare and medical technology
- Website: http://www.ysioscapital.com/
- Status: Open
- Funding type: Equity investment;
- Geographic focus: Europe;
- Public/Private: Private
- Stage focus: Seed; Series A; Series B;
- Applicant target: Startup;
Overview
Ysios Capital provides biotech ventures with the resources to develop novel therapies for indications with high unmet medical needs.
They invest in companies that will have a positive impact on patients and society and in companies bringing life-changing treatments to patients, with a focus on indications with high unmet need.
Ysios Capital has launched a new fund worth €100 million to fund pre-seed startups.
Last updated on 2026-06-02 12:19
Ysios Capital FAQ
0 questions
Ysios Capital Reviews
0 reviews
Recommend to a Friend
Experience
No data experience
Getting the funds
No data getting funds
Simple process
0 Average
Ysios Capital News
Featured Funds
- Usage: R&D;
- Entity type: Public Agency
- Total: 163M €
- Funding type: Grant;
- Status: Open
- Geographic focus: Europe; European Union;
- 0 reviews 4 questions
- Usage: R&D;
- Entity type: Public Agency
- Total: 135M €
- Funding type: Grant;
- Status: Open
- Geographic focus: Horizon Europe associated countries; Europe;
- 0 reviews 2 questions
- Usage: Scale-up;
- Entity type: Private Equity Firm
- Total: 150M €
- Status: Open
- Geographic focus: Norway; Sweden; Europe;
- 0 reviews 0 questions
Login or create an account. It's free and very fast